As of Jul 25, 2024, the Dynavax Technologies stock's PE ratio is 164.0. This takes into account the latest EPS of $0.07 and stock price of $11.48.
The PE ratio of Dynavax Technologies has averaged 30.95 over the last three years. The current P/E ratio of 164.0 is similar to the historical average. Looking back at the last three years, DVAX's PE ratio peaked in the Mar 2024 quarter at 177.29, when the price was $12.41 and the EPS was $0.07. The lowest point was in the Sep 2022 quarter, when it reached 4.02 with a price of $10.44 and an EPS of $2.6.
Maximum annual decrease: -79.77% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | 4.59 | -79.77% |
| 2021 | 22.69 | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
Currently, DVAX's PE ratio is higher than its 3, 5 and 10-year averages.
DVAX's PE ratio stands lower than its peer stock GILD, but it is higher than MRK's and AZN's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BIIB Biogen Inc | 26.23 | $30.75B |
| AZN Astrazeneca plc | 37.56 | $242.2B |
| AMGN Amgen Inc | 47.56 | $179.63B |
| MRK Merck & Co Inc | 137.65 | $317.26B |
| DVAX Dynavax Technologies Corp | 165.86 | $1.52B |
| GILD Gilead Sciences Inc | 192.53 | $95.94B |
| AGEN Agenus Inc | N/A | $137.76M |
| PFE Pfizer Inc | N/A | $174.36B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $19.37B |
The price to earnings ratio for DVAX stock as of Jul 25, 2024, stands at 164.
As an average over the last 3 years, DVAX stock has a PE ratio of 30.95.
As an average over the last 5 years, DVAX stock has a PE ratio of 30.95.
The highest quarterly PE ratio in the last three years has been 177.29 and it was in the Mar 2024 quarter.
DVAX's price to earnings ratio is currently 430% above its 3-year historical average.
DVAX's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jul 25, 2024), Dynavax Technologies's share price is $11.48. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $0.07. Therefore, Dynavax Technologies's PE ratio for today is 164. PE RATIO(164) = STOCK PRICE($11.48) / TTM EPS($0.07)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.